Marshall Wace North America’s Zymeworks ZYME Stock Holding History

Marshall Wace North America’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.18M	Buy	+40,619	New	+$1.35M	0.01%	866
2020 Q3	–	Sell	-290,524	Closed	-$10.5M	–	1521
2020 Q2	$10.5M	Sell	290,524 -8,300	-3%	-$306K	0.07%	260
2020 Q1	$10.6M	Sell	298,824 -259,015	-46%	-$10.6M	0.08%	214
2019 Q4	$25.4M	Buy	557,839 +399,993	+253%	+$14.5M	0.12%	179
2019 Q3	$3.92M	Buy	157,846 +145,408	+1,169%	+$3.64M	0.02%	410
2019 Q2	$274K	Buy	+12,438	New	+$228K	﹤0.01%	990
2018 Q3	–	Sell	-229,462	Closed	-$3.39M	–	1424
2018 Q2	$3.39M	Buy	+229,462	New	+$3.55M	0.02%	620

Other funds holding ZYME

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Marshall Wace North America's ZYME Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Zymeworks (ZYME) in Q3 2021: 40,619 shares worth $1.18M. The stake represents 0.01% of the portfolio and ranks #866 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in ZYME as recently as Q2 2020.

Marshall Wace North America first reported a position in ZYME in Q2 2018 and has held it in 7 quarters since. The position peaked at $25.4M in Q4 2019. 123 funds tracked by Wall St. Rank hold ZYME as of Q3 2021.

Marshall Wace North America held 40,619 shares of Zymeworks worth $1.18M as of Q3 2021.
Zymeworks was a new Marshall Wace North America position in Q3 2021.
Zymeworks made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #866 holding.
Marshall Wace North America first reported a position in Zymeworks in Q2 2018 and has held it in 7 quarters since.
Marshall Wace North America's Zymeworks position peaked at $25.4M in Q4 2019.
123 funds tracked by Wall St. Rank held Zymeworks as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.